SCHEMBL1032200

SCHEMBL1032200

CCCCC1=CC(=O)C=C2CC[C@@H]3[C@H](C(O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(C)=O)[C@@]12C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 13/20 0.68
▸ PGR P06401 5/20 0.68
▸ AR P10275 3/20 0.64
▸ SERPINA6 P08185 3/20 0.64
▸ LMNA P02545 3/20 0.64
▸ CHRM1 P11229 1/20 0.64
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ MAPT P10636 2/20 0.57
▸ POLB P06746 1/20 0.57
▸ GAA P10253 1/20 0.57
▸ CYP3A4 P08684 5/20 0.54
▸ HSD17B10 Q99714 4/20 0.54
▸ NR3C1 P04150 3/20 0.54
▸ CYP2C19 P33261 3/20 0.54
▸ NR3C2 P08235 2/20 0.54
▸ ABCB11 O95342 1/20 0.54
▸ TNF P01375 1/20 0.54
▸ IL6 P05231 1/20 0.54
▸ GLUL P15104 1/20 0.54
▸ ADAM17 P78536 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8750472 0.92 HIF1A (0.72) HIF1APGRARSERPINA6LMNA
SCHEMBL11876524 0.87 HIF1A (0.68) HIF1APGRARSERPINA6LMNA
SCHEMBL13232 0.87 HIF1A (0.74) HIF1APGRARSERPINA6LMNA
SCHEMBL10428758 0.86 HIF1A (0.73) HIF1APGRARSERPINA6LMNA
SCHEMBL5087747 0.85 HIF1A (0.70) HIF1APGRARSERPINA6LMNA
SCHEMBL598893 0.83 HIF1A (0.59) HIF1APGRARSERPINA6LMNA
SCHEMBL28842265 0.83 HIF1A (0.59) HIF1APGRARSERPINA6LMNA
SCHEMBL23736381 0.83 HIF1A (0.65) HIF1APGRARSERPINA6LMNA
SCHEMBL5668344 0.82 HIF1A (0.69) HIF1APGRARSERPINA6LMNA
SCHEMBL31723329 0.82 HIF1A (0.69) HIF1APGRARSERPINA6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102816241-B Albumin fusion proteins HUMAN GENOME SCIENCES INC 2015-07-22 — — CN disclosed
EP-1661892-B1 CONDENSED RING COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO (JP) 2013-07-24 — — EP disclosed
CN-102816241-A Albumin fusion proteins HUMAN GENOME SCIENCES INC 2012-12-12 — — CN disclosed
US-8318952-B2 Substituted indole derivatives for the treatment of respiratory diseases ONO PHARMACEUTICAL CO., LTD. (JP) 2012-11-27 — — US disclosed
EP-1852420-B1 Indole compounds for treating respiratory disorders ONO PHARMACEUTICAL CO (JP) 2012-10-17 — — EP disclosed
EP-2481732-A1 Condensed ring compound and use thereof Ono Pharmaceutical Co., Ltd. (JP) 2012-08-01 — — EP disclosed
EP-1481969-B1 PIPERIDINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2011-01-19 — — EP disclosed
US-20100234368-A1 CONDENSED RING COMPOUND AND USE THEREOF TAKEUCHI JUN 2010-09-16 — — US disclosed
US-7763610-B2 Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-27 — — US disclosed
US-7728023-B2 Indole compound and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-06-01 — — US disclosed
EP-1852420-A1 INDOLE COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2007-11-07 — — EP disclosed
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-22 — — US disclosed
US-20060194797-A1 Condensed ring compound and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2006-08-31 — — US disclosed
US-20060135577-A1 Remedy for chronic disease ONO PHARMACEUTICAL CO., LTD. (JP) 2006-06-22 — — US disclosed
EP-1661892-A1 CONDENSED RING COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-05-31 — — EP disclosed
EP-1616862-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-01-18 — — EP disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 — — US disclosed
EP-1550461-A1 REMEDY FOR CHRONIC DISEASE ONO PHARMACEUTICAL CO., LTD. (JP) 2005-07-06 — — EP disclosed
US-20050080107-A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-04-14 — — US disclosed
EP-1481969-A1 PIPERIDINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2004-12-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234368-A1 CONDENSED RING COMPOUND AND USE THEREOF CYSLTR2, CYSLTR1, LTB4R2 HIF1A 1982/4885PGR 2013/4885AR 862/4885
US-20060194797-A1 Condensed ring compound and use thereof CYSLTR2, CYSLTR1, LTB4R2 HIF1A 1982/4885PGR 2013/4885AR 862/4885
US-20050080107-A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient PDCD4, PDE4B, IRAK4 HIF1A 189/4885PGR 820/4885AR 2405/4885
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof HLA-DRB1, MIF, HLA-C HIF1A 340/4885PGR 450/4885AR 165/4885
US-20060135577-A1 Remedy for chronic disease EDNRA, EDNRB, LPAR2 HIF1A 3307/4885PGR 1452/4885AR 1213/4885
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 HIF1A 1472/4885PGR 589/4885AR 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback